Crossmark

Model-informed drug repurposing of proton pump inhibitors for the prevention of oxaliplatin induced peripheral neuropathy: A real-world data analysis and pharmacometrics approach

Crossref DOI link: https://doi.org/10.1007/s00280-025-04801-9

Published Online: 2025-08-07

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tsukushi, Yasuhito

Koriyama, Kanade

Kobuchi, Shinji

Matsumoto, Kenjiro

Ito, Yukako

Sakaeda, Toshiyuki
License Information

Text and Data Mining valid from 2025-08-07

Version of Record valid from 2025-08-07
More Information

Article History

Received: 10 June 2025

Accepted: 23 July 2025

First Online: 7 August 2025

Declarations

:

: The authors declare no competing interests.

: All of the animal experiments were approved by the Institutional Animal Care and Use Committee (No. A22-051), and conducted in accordance with the Kyoto Pharmaceutical University Animal Experimentation Guidelines.

Document is current

Any future updates will be listed below